Skip to content

Canadian Pharmacy Regulatory Authorities:

AB
BC
MB
NB
NL
NS
NT
NU
ON
PE
QC
SK
YT
All

Search for: 53979

National Drug Schedules Program
Resources
International
News

National Drug Schedules Program
Resources
International
News
Login
NAPRA Groups

National Drug Schedules Program
Resources
International
News
Login
NAPRA Groups

Hyoscine butylbromide

Hyoscine butylbromide

When recommended for parenteral use.

Approval Date: August 23, 2016

Schedule: I

Footnote: PDL

About NAPRA|

Canadian Pharmacy Regulatory Authorities:

AB
BC
MB
NB
NL
NS
NT
NU
ON
PE
QC
SK
YT
All

Contact

130 Albert Street, Suite 1800
Ottawa, Ontario K1P 5G4 Canada

Phone: 1 (613) 569-9658
info@napra.ca

Subscribe to Updates from NAPRA

Receive NAPRA updates of interest directly to your inbox: general NAPRA news, NDS updates and/or updates on practice resources.

SUBSCRIBE NOW

2024 © Copyright National Association of Pharmacy Regulatory Authorities. All Rights Reserved. Privacy Policy